About DAWA Limited
Marketing Authorisations holder for generic medicines.
Market Authorisations
Granted Licences by MHRA
0 +
Licences under application/development
0 +
- DAWA holds over 120 licences granted by the MHRA and over 40 are under development or application
- DAWA has an in-house regulatory department to make applications, and to maintain the Marketing Authorisations
- DAWA work with EU GMP approved Contract Manufacturing Organisations (CMO) and can facilitate the manufacture of the full range of formulations, tablets, capsules, oral suspensions, oral solutions, toothpastes, eye drops, injections...
- DAWA's products are released for sale and distribution by our sister company DRUGSRUS Limited
- Medicines manufactured under each Marketing Authorisations are released for sale under the Manufacturers Import Authorisation (MIA) held by our sister company DRUGSRUS Limited
Commercial Opportunities
In-Licencing
DAWA looks for high qaulity dossiers to in-licence - with or without supply agreements.
Out-Licencing
DAWA can out-licence dossiers with new partners.
- DAWA develops dossiers with our partners, and is open to new development partnerships
- DAWA in-licenses dossiers from partner companies, with or without a supply agreement
- DAWA is in a strong position to look at out-licensing opportunities with partners outside the UK
- DAWA has an in-house regulatory department to make applications and to maintain the Marketing Authorisations
- DAWA distributes its products via its sister company, DRUGSRUS Limited. DRUGSRUS has extensive access to the UK market supplying to all major wholesalers, medium sized wholesalers, and the NHS.